Tumour or cancer markers are produced either by the tumour itself or by the body in response to the presence of cancer or certain non-cancerous benign conditions.
AFP is used in the follow-up management of patients undergoing cancer therapy. Calcitonin helps in the diagnosis and follow-up of medullary thyroid carcinoma and of MEN type II. CEA is used in the monitoring of colorectal cancer and selected other cancers. Free bhCG is an aid in the diagnosis of testicular tumors, ovarian germ cell tumors, and teratomas, mainly.
AFP
Calcitonin
-
CT, HRP dilution buffer
-
CT, MAb, HRP concentrated conjugate
-
CT, MAb, HRP pure conjugate
-
CT, Monoclonal Antibody , clone 6H11 3E4
-
CT, Monoclonal Antibody , clone IF2 3G11
-
CT, Monoclonal Antibody , clone IF2 3G11, F(ab)'2.
-
CT, Monoclonal Antibody, clone 3B1 1C10
-
CT, Monoclonal Antibody, clone CB1
-
CT, Monoclonal Antibody, clone CB1, Biotin Conj.
CEA
Free beta-hCG
-
Free ß-hCG, Monoclonal Antibody , clone 2G7
-
Free ß-hCG, Monoclonal Antibody , clone 2G7, F(ab)'2.
-
Free ß-hCG, Monoclonal Antibody , clone 981A 3G6
-
Free ß-hCG, Monoclonal Antibody , clone 981A 3G6, F(ab)'2.
-
Free ß-hCG, Monoclonal Antibody, clone 3E8 G4 AC11
-
Free ß-hCG, Monoclonal Antibody, clone 3E8 G4 AC11, Biotin Conj.
Chromogranin-A (CgA)
Need more information?